
|Videos|April 22, 2014
Treatment Considerations for Older Patients With Lung Cancer
Author(s)Gregory J. Riely, MD, PhD
Gregory J. Riely, MD, PhD, vice chair, Clinical Trials Office, Department of Medicine, Memorial Sloan Kettering Cancer Center, discusses treatment considerations for older patients with lung cancer.
Advertisement
Clinical Pearls
Gregory J. Riely, MD, PhD, vice chair, Clinical Trials Office, Department of Medicine, Memorial Sloan Kettering Cancer Center, discusses treatment considerations for older patients with lung cancer.
- The spectrum of mutations and rearrangements that occur in lung cancer is not very specific to age.
- Some older patients have difficulty receiving conventional cytotoxic chemotherapy.
- Treatment with a targeted therapy in a patient without the target is always less effective than cytotoxic chemotherapy, no matter the patient's age.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Tentative Approval to New Cabozantinib Capsule Formulation
2
FDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies
3
In Squamous NSCLC, Cemiplimab Data Pulled the Room Away From Dual Checkpoint Blockade
4
Real-World Analysis Explores GLP-1 Use and Overall Survival
5










































